Microchip Technology Incorporated (MCHP) financials
NASDAQ · Technology · Semiconductors · 17,900 employees · CEO Steve Sanghi
- Price
- $77.34 -4.66%
- Market cap
- $42B
- Enterprise value
- $47.1B
- Last report
- Q1 '27 filed 2026-08-06
- Next report
- 2026-11-05 EPS est. $0.94
Valuation & key figures
- Market cap
- $42B EV $47.1B
- Revenue
- $5.12B Trailing 12 months
- Revenue growth
- +36% FY2027 consensus
- Profit margin
- 8.8% Net income / revenue, TTM
- P/E
- 107.2× Forward 21.2× (FY2027)
- P/S
- 8.2× Price / sales, TTM
- EV / EBITDA
- 28.0× TTM
- Free cash flow
- $1.11B Trailing 12 months
- Net income
- $451M Trailing 12 months
- Revenue estimate
- $6.41B FY2027 consensus
- Earnings
- 2026-11-05 Revenue est. $1.61B
- Dividend
- $1.82 Per share, last 12 months
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-08-06): revenue beat by 1.8%, EPS beat by 8.6%Revenue $1.48B vs $1.46B expected (+1.8%); EPS $0.76 vs $0.70 (+8.6%).
- Revenue growth accelerating: 38.0% year on yearQ1 '27 revenue $1.48B, against an average of 8.8% over the four quarters before.
- Operating margin 15.5% (TTM), +12.9 pp on a year agoOperating income grew 627.2% while revenue grew 20.9%.
- 37.2% of pre-tax profit is eaten by non-operating lossesPre-tax income $579M vs operating income $795M (TTM). Losses on equity stakes and other one-off items cut net income and EPS - operating income is the cleaner measure of the business.
- Capex 1.7% of revenue (a year ago 1.7%)$87.1M invested in the last 4 quarters (+22.7% on a year earlier). Free cash flow $1.11B = 246.5% of net income.
- Returned $985M to shareholders = 88.7% of free cash flowBuybacks $0 (a year earlier $23.8M), dividends $985M, stock-based pay $278M (TTM).
- Diluted share count up 2.1% in a year551M diluted shares in Q1 '27, 539M a year earlier.
- Net debt $5.13BCash + short-term investments $272M, debt incl. leases $5.4B; a year ago net debt $4.93B.
Last quarter: Q1 '27
Quarter ended 2026-06-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q1 '27 | Year ago | Change | |
|---|---|---|---|
| Revenue | $1.48B | $1.08B | +38.0% |
| Gross margin | 63.2% | 53.6% | +9.6 pp |
| Operating income | $337M | $32.1M | +949.2% |
| Operating margin | 22.7% | 3.0% | +19.7 pp |
| Net income | $230M | -$18.6M | +1,335.5% |
| Diluted EPS | $0.37 | -$0.09 | +529.7% |
| Operating cash flow | $512M | $276M | +85.6% |
| Capex | $13.9M | $17.9M | -22.3% |
| Free cash flow | $498M | $258M | +93.1% |
| R&D | $309M | $256M | +20.9% |
| Stock-based compensation | $75M | $52.9M | +41.8% |
Reported vs consensus
2026-08-06| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | $1.48B | $1.46B | +1.8% |
| EPS (as estimated) | $0.76 | $0.70 | +8.6% |
From the report of 2026-08-06 for Q1 '27: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyRevenue by business line
stacked, quarterly| Segment | Q1 '27 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| Semiconductor Products Member | $1.44B | +38.3% | 97.1% | $4.95B | +20.9% | |
| Technology Licensing Member | $42.6M | +29.1% | 2.9% | $173M | +22.2% |
Margins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- $1.2B
- Capex
- -$87.1M
- Buybacks
- $0
- Dividends
- -$985M
- Acquisitions
- $0
- Net debt issued
- -$91M
- Stock-based compensation
- $278M
- Free cash flow
- $1.11B
- Returned to shareholders / FCF
- 88.7%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | 107.2× | 79.4× 4 of 5 years | 20.6× – 239.3× |
| EV / EBITDA | 28.0× | 20.8× | 12.8× – 29.7× |
| EV / Sales | 9.2× | 7.2× | 6.2× – 8.5× |
| Price / FCF | 37.8× | 24.8× | 14.7× – 40.2× |
| Price / Book | 6.5× | 6.1× | 3.7× – 7.3× |
| FCF yield | 2.6% | 4.7% | 2.5% – 6.8% |
| Return on invested capital | 5.0% | 8.9% | -0.0% – 16.3% |
| Return on equity | 6.9% | 17.6% | -0.0% – 34.4% |
Analysts
Consensus target $110.50 (+42.9%)
range $88.00 – $135.00 · rating Buy
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2027 | $6.41B | +35.9% | $3.65 | +1,304.5% | 21.2× | 17 |
| FY2028 | $7.47B | +16.6% | $4.59 | +25.7% | 16.8× | 17 |
| FY2029 | $8.24B | +10.3% | $5.23 | +13.9% | 14.8× | 5 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Every reported line
All 272 figures Microchip Technology Incorporated tagged in its recent 10-Q / 10-K filings, with the official SEC label and definition - including the notes (leases, taxes, buybacks, employees, ...).
| Line (SEC label) | Latest quarter | Year ago | y/y | Latest FY | Prior FY | y/y |
|---|---|---|---|---|---|---|
| – | – | – | -$2.6M | – | – | |
| – | – | – | -0.9% | – | – | |
| – | – | – | $43M | – | – | |
| – | – | – | 15.7% | – | – | |
| – | – | – | $166M | – | – | |
| – | – | – | $3.4M | – | – | |
| Accounts Payable, Current | $229M | $162M | +41.4% | $206M | $161M | +28.0% |
| Accounts Receivable, after Allowance for Credit Loss, Current | $968M | $766M | +26.4% | $895M | $690M | +29.7% |
| Accounts Receivable, Allowance for Credit Loss, Current | $5.3M | $5.7M | -7.0% | $5.3M | $5.9M | -10.2% |
| Accounts Receivable, before Allowance for Credit Loss, Current | $973M | $771M | +26.2% | $900M | $696M | +29.4% |
| Accrued Income Taxes, Current | $43.1M | $86.2M | -50.0% | $24.3M | $99.1M | -75.5% |
| Accrued Income Taxes, Noncurrent | $580M | $640M | -9.4% | $571M | $633M | -9.9% |
| Accrued Liabilities and Other Liabilities | $270M | $251M | +7.3% | $218M | $209M | +4.5% |
| Accrued Liabilities, Current | $1.07B | $1.03B | +3.6% | $931M | $995M | -6.4% |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $2.64B | $2.37B | +11.1% | $2.6B | $2.34B | +11.2% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | -$3.7M | -$6.4M | +42.2% | -$4.2M | -$1.7M | -147.1% |
| Additional Paid in Capital, Common Stock | $4.12B | $3.97B | +3.6% | $4.07B | $3.91B | +4.1% |
| Amortization of Debt Discount (Premium) | $3.9M | $1.4M | +178.6% | $27.2M | $64.8M | -58.0% |
| Amortization of Debt Issuance Costs | $2.3M | $1.4M | +64.3% | $5.9M | $7.8M | -24.4% |
| Amortization of Intangible Assets | $119M | $132M | -9.7% | $534M | $584M | -8.6% |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | $77.7M | $52.3M | +48.6% | $260M | $190M | +37.4% |
| Asset Impairment Charges | – | – | – | $400K | $0 | – |
| Assets | $14.4B | $15B | -3.8% | $14.4B | $15.4B | -6.5% |
| Assets, Current | $2.49B | $2.75B | -9.7% | $2.38B | $2.99B | -20.5% |
| Business Exit Costs | – | – | – | $14.5M | $45.7M | -68.3% |
| Cash and Cash Equivalents, at Carrying Value | $272M | $567M | -51.9% | $240M | $772M | -68.9% |
| Cash and Cash Equivalents, Fair Value Disclosure | $02026-03-31 | $491M | -100.0% | $0 | $491M | -100.0% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $272M | $567M | -51.9% | $240M | $772M | -68.9% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $32M | -$205M | +115.6% | -$531M | $452M | -217.6% |
| Common Stock, Dividends, Per Share, Cash Paid | – | – | – | $1.82 | $1.82 | +0.2% |
| Common Stock, Dividends, Per Share, Declared | $0.46 | $0.46 | 0.0% | $1.82 | $1.82 | +0.2% |
| Common Stock, Par or Stated Value Per Share | $0.00 | $0.00 | 0.0% | $0.00 | $0.00 | 0.0% |
| Common Stock, Shares Authorized | 900M | 900M | 0.0% | 900M | 900M | 0.0% |
| Common Stock, Shares, Issued | 578M | 578M | 0.0% | 578M | 578M | +0.1% |
| Common Stock, Shares, Outstanding | 543M | 540M | +0.6% | 542M | 539M | +0.6% |
| Common Stock, Value, Issued | $600K | $600K | 0.0% | $600K | $600K | 0.0% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $230M | -$23.3M | +1,088.4% | $228M | $1.3M | +17,400.0% |
| Cost of Revenue | $546M | $499M | +9.4% | $1.99B | $1.93B | +3.0% |
| Current Federal Tax Expense (Benefit) | – | – | – | $51.7M | $128M | -59.5% |
| Current Foreign Tax Expense (Benefit) | – | – | – | $52.9M | $55.2M | -4.2% |
| Current Income Tax Expense (Benefit) | – | – | – | $108M | $183M | -40.8% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $3.5M | $0 | – |
| Debt Instrument, Face Amount | $1K | $1K | 0.0% | $1K | $1K | 0.0% |
| Debt Instrument, Unamortized Discount | $8.4M | $11.4M | -26.3% | $9.3M | $13.1M | -29.0% |
| Debt Issuance Costs, Net | $29.2M | $18.5M | +57.8% | $31.2M | $19.5M | +60.0% |
| Deferred Federal Income Tax Expense (Benefit) | – | – | – | -$21.6M | -$101M | +78.6% |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | -$40.8M | -$36.8M | -10.9% |
| Deferred Income Tax Assets, Net | $1.78B | $1.73B | +2.7% | $1.79B | $1.73B | +3.7% |
| Deferred Income Tax Expense (Benefit) | $11.4M | -$3M | +480.0% | -$64.6M | -$143M | +54.9% |
| Deferred Income Tax Liabilities, Net | $25.4M | $36.3M | -30.0% | $25.1M | $33.8M | -25.7% |
| Deferred Revenue, Current | $174M | $160M | +8.8% | $179M | $213M | -16.0% |
| Deferred State and Local Income Tax Expense (Benefit) | – | – | – | -$2.2M | -$5.5M | +60.0% |
| Deferred Tax Assets, Capital Loss Carryforwards | $10.1M2026-03-31 | $9.8M | +3.1% | $10.1M | $9.8M | +3.1% |
| Deferred Tax Assets, Goodwill and Intangible Assets | $1.08B2026-03-31 | $1.19B | -9.3% | $1.08B | $1.19B | -9.3% |
| Deferred Tax Assets, Gross | $2.12B2026-03-31 | $2.07B | +2.9% | $2.12B | $2.07B | +2.9% |
| Deferred Tax Assets, Inventory | $145M2026-03-31 | $130M | +10.8% | $145M | $130M | +10.8% |
| Deferred Tax Assets, Net | $1.77B2026-03-31 | $1.69B | +4.3% | $1.77B | $1.69B | +4.3% |
| Deferred Tax Assets, Net of Valuation Allowance | $1.83B2026-03-31 | $1.78B | +3.1% | $1.83B | $1.78B | +3.1% |
| Deferred Tax Assets, Operating Loss Carryforwards | $62.4M2026-03-31 | $59.3M | +5.2% | $62.4M | $59.3M | +5.2% |
| Deferred Tax Assets, Property, Plant and Equipment | $15.4M2026-03-31 | $0 | – | $15.4M | $0 | – |
Source: SEC companyfacts (XBRL of every 10-Q / 10-K). Cash-flow quarters are derived from the year-to-date figures the 10-Q tags. Segment breakdowns are tagged with dimensions and are shown in the segment section instead.
Sources
Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-K 2026-03-31, 10-Q 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-K 2025-03-31, 10-Q 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
Data as of 2026-11-02